{"filing":{"accession_number":"0001437749-26-030505","cik":"0001617867","ticker":"AMIX","company_name":"Autonomix Medical, Inc.","form":"8-K","filing_date":"2026-09-16","report_date":"2026-09-14","primary_document":"amix20260914_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1617867/000143774926030505/amix20260914_8k.htm"},"events":[{"id":33792,"run_id":31093,"accession_number":"0001437749-26-030505","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of Sandra Kalter as an independent board member effective September 14, 2026, with the Board increasing from five to six members. The principal disclosed action is a person taking a role (board director), making this an exec_appointment. Kalter's extensive background—20 years at Medtrocket as Chief Regulatory Counsel, involvement with 27+ acquisitions, and deep FDA/regulatory expertise—makes this materially significant to investors evaluating the company's governance and strategic direction.","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-09-16","form":"8-K","submitted_at":null,"items":[{"id":37324,"accession_number":"0001437749-26-030505","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Sandra Kalter as an independent board member effective September 14, 2026, with the Board increasing from five to six members. The principal disclosed action is a person taking a role (board director), making this an exec_appointment. Kalter's extensive background—20 years at Medtrocket as Chief Regulatory Counsel, involvement with 27+ acquisitions, and deep FDA/regulatory expertise—makes this materially significant to investors evaluating the company's governance and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-16T12:36:38.363727+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37324,"accession_number":"0001437749-26-030505","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Sandra Kalter as an independent board member effective September 14, 2026, with the Board increasing from five to six members. The principal disclosed action is a person taking a role (board director), making this an exec_appointment. Kalter's extensive background—20 years at Medtrocket as Chief Regulatory Counsel, involvement with 27+ acquisitions, and deep FDA/regulatory expertise—makes this materially significant to investors evaluating the company's governance and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-16T12:36:38.363727+00:00","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-09-16"}]}